Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats

Coronary Artery Disease

Volumn 16, Issue 4, 2005, Pages 245-255

  Xu, Xiaohua ^a   Xu, Zenglu ^a   Xu, Yuanyuan ^a   Cui, Guanghui ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Coronary disease; Extracellular matrix; Mesenchymal stem cell; Myocardial infarction; Remodeling; Transplantation

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COMPLEMENTARY DNA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE REMODELING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BASE SEQUENCE; BIOPSY, NEEDLE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 1; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR SEQUENCE DATA; MYOCARDIAL INFARCTION; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 20644471364     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200506000-00006     Document Type: Article

References (32)

1. Tsuda T, Gao E, Evangelisti L, Mardova D, Ma X, Chu ML. Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc Res 2003; 59:926-933.
2. Beltrami AP, Urbanek K, Kajstura J, Van SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344:1750-1757.
3. Soonpaa MH, Koh GY, Klug MG, Field U. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994; 264:98-101.
4. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60: 12-18.
5. Li RK, Mickle DA, Weisel RD, Zhang J, Mohabeer MK. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 1996; 78:283-288.
6. Min JY, Yang Y, Converse KL, Liu L, Huang Q, Morgan JP, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002; 92:288-296.
7. Tomita S, Li R-K, Weisel RD, Mickle DAG, Kim E-J, Sakai T, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100(suppl II):II-247-II-256.
8. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701-705.
9. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, Edge AS, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001; 103:1920-1927.
10. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cells transplantation. J Thorac Cardiovasc Surg 2002; 123:1132-1140.
11. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003; 108:863-868.
12. Reffer MA, Reffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, ef a/. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44:503-512.
13. Mulder P, Boujedaini H, Richard V, Henry JP, Renet S, Munter K, et al. Long-term survival and hemodynamics after endothelin-A receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure. Circulation 2002; 106:1159-1164.
14. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 1994; 89:397-410.
15. Makino S, Fukuda K, Miyoshi S, Konishi F, Dodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103:697-705.
16. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105:93-98.
17. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002; 73: 1919-1926.
18. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9:1195-1201.
19. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18:1417-1426.
20. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103:697-705.
21. Mckay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986; 74:693-702.
22. Yoshiyama M, Takeuchi K, Omura T, Kim S, Yamagishi H, Toda I, et al. Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. Hypertension 1999; 33:961-968.
23. Sun Y, Zhang JQ, Zhang J, Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 2000; 135:316-323.
24. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003; 108:1395-1403.
25. Moritani H, Kusachi S, Takeda K, Doi M, Ohnishi H, Komatsubara I, et al. Reperfusion accelerates the distribution of type I and III collagen messenger RNA expression after acute myocardial infarction: in situ hybridization in experimental infarction. Coron Artery Dis 1999; 10:89-96.
26. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ 3rd, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998; 97:1708-1715.
27. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999; 99:3063-3070.
28. Spinale FG, Coker ML, Heung U, Bond BR, Gunasinghe HR, Etoh T, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000; 102:1944-1949.
29. Spinale FG, Coker ML, Krombach SR, Mukherjee R, Hallak H, Houck WV, et al. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res 1999; 85:364-376.
30. Lijnen PJ, Petrov W, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-β. Mol Genet Metab 2000; 71: 418-435.
31. Deten A, Hölzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 2001; 33:1191-1207.
32. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, et al. Alteration in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res 1994; 75:23-32.